NCT05191602 is a clinical trial of drainge fluid in Anastomotic Leakage, sponsored by Southwest Hospital, China.

Who is sponsoring NCT05191602?

NCT05191602 is sponsored by Southwest Hospital, China.

What drugs are being tested in NCT05191602?

Interventions in NCT05191602: drainge fluid.

What condition does NCT05191602 study?

NCT05191602 studies Anastomotic Leakage.

Is NCT05191602 still recruiting?

NCT05191602 is currently status unknown. Last updated 13 January 2022.

Last reviewed 2022-01-13 · How we verify

NCT05191602

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Relationship Between Drainage Fluid and Anastomotic Leakage After Colorectal Cancer Surgery

Status unknown Last updated 13 January 2022

What this trial tests

trial testing drainge fluid in Anastomotic Leakage in 300 participants. Status unknown.

Timeline

1 July 2021

Primary endpoint
30 June 2023

1 December 2023

Quick facts

Lead sponsor	Southwest Hospital, China
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 July 2021
Primary completion	30 June 2023
Estimated completion	1 December 2023
Sites	1 location across China

Drugs / interventions tested

drainge fluid

Conditions studied

Anastomotic Leakage — all drugs for Anastomotic Leakage →

Sponsor

Southwest Hospital, China

Who can join

Adults 18 to 75, any sex, with Anastomotic Leakage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective and analytical study on the detection of early anastomotic leakage by abdominal drainage fluid after colorectal cancer surgery. pay attention to indicators including bilirubin

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anastomotic Leakage

Currently open trials in the same condition.

NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
NCT07208786 — Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery · NA · recruiting
NCT06865638 — Efficacy and Safety of Colorectal Anastomotic Leak Testing · NA · recruiting
NCT06464978 — Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy · NA · recruiting
NCT05826743 — Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy · NA · recruiting

Other Southwest Hospital, China trials

Trials by the same sponsor.

NCT07469293 — Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke · Phase 3 · not yet recruiting
NCT07294209 — Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients · Phase 4 · recruiting
NCT07251374 — Osteomyelitis Multi-center Prospective Cohort Study · not yet recruiting
NCT06894433 — Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage · NA · recruiting
NCT06791538 — Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05191602 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Southwest Hospital, China
Last refreshed: 13 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05191602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing